-
PharmacoEconomics Jan 2022
Topics: Economics, Medical; Economics, Pharmaceutical; Humans; Publishing
PubMed: 34921351
DOI: 10.1007/s40273-021-01111-9 -
Journal Francais D'ophtalmologie Oct 2020
Topics: Adult; Biomedical Research; Blindness; Device Approval; France; Fund Raising; Germany; Humans; Implants, Experimental; Product Recalls and Withdrawals; Prosthesis Failure; Prosthesis Implantation; Retina; Retinal Diseases; Societies, Medical; United States; Visual Prosthesis
PubMed: 32622631
DOI: 10.1016/j.jfo.2020.06.003 -
JAMA Apr 2023
Topics: Humans; Physicians; Surveys and Questionnaires; Economics, Medical; Fees, Medical
PubMed: 37071106
DOI: 10.1001/jama.2022.15873 -
Sleep Medicine Clinics Sep 2020As part of an efficient, continuously improving care delivery system, telehealth can increase patient engagement by creating new or additional ways of communicating with... (Review)
Review
As part of an efficient, continuously improving care delivery system, telehealth can increase patient engagement by creating new or additional ways of communicating with patients' physicians. Telehealth has the potential to increase patient and primary care provider access to specialists, provide specialist support to rural providers, assist with on-going monitoring and support for patients with chronic conditions, and reduce health care expenses by maximizing the use of specialists without the need to duplicate coverage in multiple locations. Current and future physicians will need to develop competencies that will enable them to navigate this new telehealth landscape.
Topics: Delivery of Health Care; Economics, Medical; Humans; Telemedicine
PubMed: 32762976
DOI: 10.1016/j.jsmc.2020.06.005 -
JAMA Sep 2019
Topics: Drug and Narcotic Control; Economics; Economics, Medical; Expert Testimony; History, 20th Century; Humans; Public Health; Social Medicine; United States
PubMed: 31528997
DOI: 10.1001/jama.2018.15517 -
Deutsches Arzteblatt International Jul 2019
Topics: Fees, Medical; Humans
PubMed: 31431241
DOI: 10.3238/arztebl.2019.0487b -
Personalized Medicine May 2021Tweetable abstract Health economics and ELSI can be better integrated to consider the family impacts of genetic and genomic testing.
Tweetable abstract Health economics and ELSI can be better integrated to consider the family impacts of genetic and genomic testing.
Topics: Cost-Benefit Analysis; Economics, Medical; Ethics, Medical; Family; Genetic Testing; Humans; Interdisciplinary Research; Legislation, Medical
PubMed: 33728981
DOI: 10.2217/pme-2021-0016 -
Health Economics May 2020
Topics: Developing Countries; Economics; Economics, Medical; Health Planning; Humans
PubMed: 32239621
DOI: 10.1002/hec.3971 -
Journal of the National Cancer... Jul 2022Cancer screening has long been considered a worthy public health investment. Health economics offers the theoretical foundation and research methodology to understand... (Review)
Review
Cancer screening has long been considered a worthy public health investment. Health economics offers the theoretical foundation and research methodology to understand the demand- and supply-side factors associated with screening and evaluate screening-related policies and interventions. This article provides an overview of health economic theories and methods related to cancer screening and discusses opportunities for future research. We review 2 academic disciplines most relevant to health economics research in cancer screening: applied microeconomics and decision science. We consider 3 emerging topics: cancer screening policies in national as well as local contexts, "choosing wisely" screening practices, and targeted screening efforts for vulnerable subpopulations. We also discuss the strengths and weaknesses of available data sources and opportunities for methodological research and training. Recommendations to strengthen research infrastructure include developing novel data linkage strategies, increasing access to electronic health records, establishing curriculum and training programs, promoting multidisciplinary collaborations, and enhancing research funding opportunities.
Topics: Early Detection of Cancer; Economics, Medical; Forecasting; Humans; Neoplasms; Public Health
PubMed: 35788368
DOI: 10.1093/jncimonographs/lgac008 -
Journal of Medical Economics 2023We review medical economics literature presented at the 2023 annual AEA-ASSA convention, the largest gathering of economists worldwide. Pharmacoeconomic papers addressed... (Review)
Review
We review medical economics literature presented at the 2023 annual AEA-ASSA convention, the largest gathering of economists worldwide. Pharmacoeconomic papers addressed a wide range of issues, including gender and racial gaps in clinical trials, hospital credit financing, drug rebates, covid-19 vaccine equality, and the opioid epidemic. Yet, they had some common identifiable themes. We examine them in the context of the "twin towers" of biopharmaceutical innovation: and . Implementation outcomes and relative success of innovative solutions - whether in terms of products and services, structural design and arrangements, or policies - depend on how adequately they respond to questions and challenges that arise in drug discovery and commercialization, and who gains from them. That innovation's beneficiaries might not equally gain from its intended advantages is another unifying theme in the reviewed literature. Against this backdrop, biopharmaceutical innovation can breed new challenges and opportunities. And health policy can perform a critical, leveling function that reduces cost, increases access, and ensures quality of biopharmaceutical solutions.
Topics: Humans; COVID-19 Vaccines; Economics, Pharmaceutical; Health Policy; Drug Discovery; Biological Products
PubMed: 37807944
DOI: 10.1080/13696998.2023.2262840